<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>54-METABOLIZED-ANTICONVULSANTS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="METABOLIZED ANTICONVULSANTS" code="N03A-002" /></DRUG1>
<DRUG2>
<DRUG name="ST JOHNS WORT" >
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
<ATC code="258326" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of decrease of the plasma concentrations and of the effectiveness of the anticonvulsant

.</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
